{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:37:59Z","timestamp":1782729479486,"version":"3.54.5"},"reference-count":144,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpet.2026.104889","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:19:56Z","timestamp":1776107996000},"page":"104889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The roles of free-fatty acid receptors in the pathophysiology of renal disorders"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2144-9913","authenticated-orcid":false,"given":"Priyanka F.","family":"Karmokar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-0355","authenticated-orcid":false,"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-4339","authenticated-orcid":false,"given":"Nader H.","family":"Moniri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jpet.2026.104889_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41581-024-00829-x","article-title":"Kidney disease: a global health priority","volume":"20","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.jpet.2026.104889_bib2","doi-asserted-by":"crossref","first-page":"iii81","DOI":"10.1093\/ndt\/gfs270","article-title":"Current drug development challenges in chronic kidney disease (CKD)\u2013identification of individualized determinants of renal progression and premature cardiovascular disease (CVD)","volume":"27","author":"Formentini","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.jpet.2026.104889_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: definition and classification of CKD","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"issue":"7951","key":"10.1016\/j.jpet.2026.104889_bib6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/d41586-023-00655-4","article-title":"Chronic kidney disease: highlights from research","volume":"615","author":"Eisenstein","year":"2023","journal-title":"Nature"},{"issue":"9888","key":"10.1016\/j.jpet.2026.104889_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jpet.2026.104889_bib8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jamia\/ocaf118","article-title":"Enhancing end-stage renal disease outcome prediction: a multisourced data-driven approach","volume":"33","author":"Li","year":"2025","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N Engl J Med"},{"issue":"9843","key":"10.1016\/j.jpet.2026.104889_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.1998.00210.x","article-title":"Treatment of acute renal failure","volume":"54","author":"Star","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MNH.0b013e328337bba7","article-title":"Temporal trends in the burden of chronic kidney disease in the United States","volume":"19","author":"Foley","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1016\/j.jpet.2026.104889_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneph.2011.84","article-title":"New era for drug discovery and development in renal disease","volume":"7","author":"Miyata","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib15","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.3390\/ijms23105354","article-title":"Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation","volume":"23","author":"Magliocca","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104889_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072909","article-title":"Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts","volume":"380","author":"Ong","year":"2023","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/CM9.0000000000000228","article-title":"Roles of short-chain fatty acids in kidney diseases","volume":"132","author":"Li","year":"2019","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/fsn3.121","article-title":"Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties","volume":"2","author":"Abedi","year":"2014","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.jpet.2026.104889_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114465","article-title":"The role of lipotoxicity in kidney disease: from molecular mechanisms to therapeutic prospects","volume":"161","author":"Ren","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"10.1016\/j.jpet.2026.104889_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161783","article-title":"Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury","volume":"7","author":"Rinaldi","year":"2022","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal lipid metabolism and lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"20","key":"10.1016\/j.jpet.2026.104889_bib22","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.3390\/cells11203236","article-title":"The contribution of lipotoxicity to diabetic kidney disease","volume":"11","author":"Schelling","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","article-title":"Mechanisms of diabetic kidney disease and established and emerging treatments","volume":"22","author":"Martinez Leon","year":"2026","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","article-title":"The key role of altered tubule cell lipid metabolism in kidney disease development","volume":"106","author":"Lee","year":"2024","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.jpet.2026.104889_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tips.2017.06.006","article-title":"FFA4\/GPR120: pharmacology and therapeutic opportunities","volume":"38","author":"Milligan","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","article-title":"Complex pharmacology of free fatty acid receptors","volume":"117","author":"Milligan","year":"2017","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/ijms17040450","article-title":"Nutritional signaling via free fatty acid receptors","volume":"17","author":"Miyamoto","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bph.12327","article-title":"Drugs or diet?\u2013Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs","volume":"170","author":"Dranse","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2026.104889_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104604","article-title":"Free fatty acid receptors as new potential therapeutic target in inflammatory bowel diseases","volume":"152","author":"Bartoszek","year":"2020","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free fatty acid receptors in health and disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib31","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ajpath.2018.01.009","article-title":"A newly discovered antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84","volume":"188","author":"Gagnon","year":"2018","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202401598","article-title":"Renal protection of HWL-088and ZLY-032, two dual GPR40\/PPAR\u03b4 agonists, in adenine-induced renal fibrosis model","volume":"22","author":"Geng","year":"2025","journal-title":"Chem Biodivers"},{"issue":"14","key":"10.1016\/j.jpet.2026.104889_bib33","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.3390\/ijms20143386","article-title":"Anti-apoptotic effect of G-protein-coupled receptor 40 activation on tumor necrosis factor-\u03b1-induced injury of rat proximal tubular cells","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.jpet.2026.104889_bib34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1042\/CS20190479","article-title":"PBI-4050 via GPR40 activation improves adenine-induced kidney injury in mice","volume":"133","author":"Thibodeau","year":"2019","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120365","article-title":"Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12935-023-02967-x","article-title":"Free-fatty acid receptor-1 (FFA1\/GPR40) promotes papillary RCC proliferation and tumor growth via Src\/PI3K\/AKT\/NF-\u03baB but suppresses migration by inhibition of EGFR, ERK1\/2, STAT3 and EMT","volume":"23","author":"Karmokar","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jpet.2026.104889_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110056","article-title":"Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis","volume":"126","author":"Huang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.113.087783","article-title":"The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism","volume":"84","author":"Hudson","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"Pt 1","key":"10.1016\/j.jpet.2026.104889_bib39","article-title":"Omega-3 polyunsaturated fatty acids alleviate hyperuricemic nephropathy by inhibiting renal pyroptosis through GPR120","volume":"230","author":"Yang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jpet.2026.104889_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109172","article-title":"Protective effects of GPR120 agonist-programmed macrophages on renal interstitial fibrosis in unilateral ureteral obstruction (UUO) rats","volume":"117","author":"Wang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41401-020-00520-4","article-title":"Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy","volume":"42","author":"Wei","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib42","article-title":"Evaluation of serum GPR-120 levels in diabetic patients with and without nephropathy: a comparative study on lipid and renal parameters","volume":"17","author":"Singh","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jpet.2026.104889_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115590","article-title":"Free-fatty acid receptor-4 (FFA4\/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells","volume":"213","author":"Karmokar","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2017.03.071","article-title":"Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-\u03b1-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells","volume":"486","author":"Kobayashi","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpet.2026.104889_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1127845","article-title":"Ketogenic diet alleviates renal fibrosis in mice by enhancing fatty acid oxidation through the free fatty acid receptor 3 pathway","volume":"10","author":"Qiu","year":"2023","journal-title":"Front Nutr"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib46","article-title":"Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways","volume":"1865","author":"Mikami","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jpet.2026.104889_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4074832","article-title":"Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-\u03ba B signaling","volume":"2020","author":"Huang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib48","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1681\/ASN.2019101029","article-title":"Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A","volume":"31","author":"Li","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7150\/ijbs.64665","article-title":"GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK\/EGR1 pathway","volume":"18","author":"Lu","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib50","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.7150\/thno.56598","article-title":"GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPK\u03b1 activity","volume":"11","author":"Lu","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12944-023-01949-2","article-title":"ACT001 alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43\/AMPK pathway","volume":"22","author":"Zhou","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jpet.2026.104889_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729382","article-title":"Short chain fatty acids prevent glyoxylate-induced calcium oxalate stones by GPR43-dependent immunomodulatory mechanism","volume":"12","author":"Jin","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib53","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3892\/mmr.2017.6762","article-title":"Targeted inhibition of endoplasmic reticulum stress: new hope for renal fibrosis (review)","volume":"16","author":"Ke","year":"2017","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000437235","article-title":"Sodium citrate inhibits endoplasmic reticulum stress in rats with adenine-induced chronic renal failure","volume":"42","author":"Ou","year":"2015","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00041552-200205000-00006","article-title":"Role of apoptosis in the pathogenesis of acute renal failure","volume":"11","author":"Bonegio","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103466","article-title":"From inflammation to renal fibrosis: a one-way road in autoimmunity?","volume":"23","author":"Roccatello","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.23876\/j.krcp.22.159","article-title":"An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles","volume":"42","author":"Wang","year":"2023","journal-title":"Kidney Res Clin Pract"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib59","first-page":"96","article-title":"Fibrosis\u2013a common pathway to organ injury and failure","volume":"373","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse origins of the myofibroblast\u2014implications for kidney fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104889_bib61","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bph.70334","article-title":"The role of free-fatty acid receptors FFA1 and FFA4 in organ fibrosis","volume":"183","author":"Karmokar","year":"2026","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib62","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1096\/fj.201601359RR","article-title":"Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis","volume":"31","author":"Overstreet","year":"2017","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1681\/ASN.2011070645","article-title":"EGFR signaling promotes TGF\u03b2-dependent renal fibrosis","volume":"23","author":"Chen","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpet.2026.104889_bib64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2018.12.069","article-title":"Discovery of first-in-class thiazole-based dual FFA1\/PPAR\u03b4 agonists as potential anti-diabetic agents","volume":"164","author":"Li","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jpet.2026.104889_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103209","article-title":"Discovery of HWL-088: a highly potent FFA1\/GPR40 agonist bearing a phenoxyacetic acid scaffold","volume":"92","author":"Li","year":"2019","journal-title":"Bioorg Chem"},{"issue":"11","key":"10.1016\/j.jpet.2026.104889_bib66","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/jphp.13342","article-title":"HWL-088, a new and highly effective FFA1\/PPAR\u03b4 dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis","volume":"72","author":"Hu","year":"2020","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jpet.2026.104889_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2016.11.009","article-title":"PPARs and nonalcoholic fatty liver disease","volume":"136","author":"Liss","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.jpet.2026.104889_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13098-019-0403-4","article-title":"Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management","volume":"11","author":"Sulaiman","year":"2019","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib69","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/er.2003-0018","article-title":"From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors\/cytokines","volume":"25","author":"Schrijvers","year":"2004","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib70","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpet.2026.104889_bib71","article-title":"Epidemiological research on diabetic nephropathy at global, regional, and national levels from 1990 to 2021: an analysis derived from the global burden of disease 2021 study","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.104889_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib73","first-page":"73","article-title":"Diabetic kidney disease; review of the current knowledge","volume":"2","author":"Shahbazian","year":"2013","journal-title":"J Renal Inj Prev"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40620-019-00650-x","volume":"33","author":"Pugliese","year":"2020","journal-title":"J Nephrol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib75","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s00125-012-2650-x","article-title":"G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1","volume":"55","author":"Ferdaoussi","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib76","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ckj\/sfz091","article-title":"Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated","volume":"13","author":"Wong","year":"2020","journal-title":"Clin Kidney J"},{"issue":"9","key":"10.1016\/j.jpet.2026.104889_bib77","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.ekir.2021.05.020","article-title":"Treatment of iron deficiency anemia in CKD and end-stage kidney disease","volume":"6","author":"Guti\u00e9rrez","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib79","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2215\/CJN.06020809","article-title":"Transfusion burden among patients with chronic kidney disease and anemia","volume":"5","author":"Lawler","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib80","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12882-022-02778-8","article-title":"Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study","volume":"23","author":"Lamerato","year":"2022","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib81","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"Pt 6","key":"10.1016\/j.jpet.2026.104889_bib82","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.104889_bib83","article-title":"SP345 activation of the free-fatty acid receptor GPR40 improves anemia in mouse models of kidney disease via a novel epo-independent mechanism of action","volume":"34","author":"Gagnon","year":"2019","journal-title":"Nephrol Dial Trans"},{"issue":"12","key":"10.1016\/j.jpet.2026.104889_bib84","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib85","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"10.1016\/j.jpet.2026.104889_bib86","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.ejca.2012.05.002","article-title":"Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma\u2013a multicentre study","volume":"48","author":"Steffens","year":"2012","journal-title":"Eur J Cancer"},{"issue":"10451","key":"10.1016\/j.jpet.2026.104889_bib87","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","article-title":"Renal cell carcinoma","volume":"404","author":"Young","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11864-018-0521-5","article-title":"Evolving treatment paradigms in non-clear cell kidney cancer","volume":"19","author":"Vaishampayan","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104889_bib89","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4161\/cbt.10.7.13247","article-title":"Signaling pathways in renal cell carcinoma","volume":"10","author":"Banumathy","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"10.1016\/j.jpet.2026.104889_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112636","article-title":"BMP-7 enhances cell migration and \u03b1v\u03b23 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib91","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1535-7163.MCT-17-0927","article-title":"Metformin suppresses tumor progression by inactivating stromal fibroblasts in ovarian cancer","volume":"17","author":"Xu","year":"2018","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib92","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181711","article-title":"Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci Rep"},{"issue":"7","key":"10.1016\/j.jpet.2026.104889_bib93","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"Hirai","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"10.1016\/j.jpet.2026.104889_bib94","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.leukres.2005.05.004","article-title":"Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines","volume":"29","author":"Garc\u00eda","year":"2005","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.104889_bib95","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib96","first-page":"71","article-title":"EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma","volume":"6","author":"Cossu-Rocca","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib97","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib98","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/PAP.0000000000000018","article-title":"Epithelial-to-mesenchymal transition in renal neoplasms","volume":"21","author":"He","year":"2014","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40291-016-0192-5","article-title":"Epithelial to mesenchymal transition in renal cell carcinoma: implications for cancer therapy","volume":"20","author":"Piva","year":"2016","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.104889_bib101","article-title":"#6747 activation of GPR120 improves the senescence of tubular epithelial cells in septic acute kidney injury","volume":"38","author":"Yang","year":"2023","journal-title":"Nephrol Dial Trans"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib102","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1253\/circj.CJ-20-0406","article-title":"Uric acid as a risk factor for chronic kidney disease and cardiovascular disease \u2013 Japanese guideline on the management of asymptomatic hyperuricemia","volume":"85","author":"Hisatome","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jpet.2026.104889_bib103","article-title":"Pyroptosis: a new frontier in kidney diseases","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jpet.2026.104889_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.01.021","article-title":"Free-fatty acid receptor-4 (GPR120): cellular and molecular function and its role in metabolic disorders","volume":"110\u2013111","author":"Moniri","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2026.104889_bib106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2015.03.094","article-title":"Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages","volume":"785","author":"Im","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2017.03.001","article-title":"GPR120 in adipocytes has differential roles in the production of pro-inflammatory adipocytokines","volume":"486","author":"Hasan","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imm.12296","article-title":"The fish oil ingredient, docosahexaenoic acid, activates cytosolic phospholipase A2 via GPR120 receptor to produce prostaglandin E2 and plays an anti-inflammatory role in macrophages","volume":"143","author":"Liu","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jpet.2026.104889_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bcp.2017.09.008","article-title":"Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal \u03b2-arrestin phosphosensor in Raw 264.7 macrophages","volume":"146","author":"Cheshmehkani","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4049\/jimmunol.1800637","article-title":"Activation of the omega-3 fatty acid receptor GPR120 protects against focal cerebral ischemic injury by preventing inflammation and apoptosis in mice","volume":"202","author":"Ren","year":"2019","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib111","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104889_bib112","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s42255-020-00296-1","article-title":"Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice","volume":"2","author":"McCommis","year":"2020","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jpet.2026.104889_bib114","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s42255-020-00322-2","article-title":"Publisher correction: mitochondrial pyruvate carriers are required for myocardial stress adaptation","volume":"2","author":"Zhang","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.jpet.2026.104889_bib115","article-title":"Fatty acid \u03b2-oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104889_bib116","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease","volume":"14","author":"Yang","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib117","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.jpet.2026.104889_bib118","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneph.2009.184","article-title":"An update on the lipid nephrotoxicity hypothesis","volume":"5","author":"Ruan","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104889_bib119","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11892-019-1263-x","article-title":"Crosstalk between lipids and mitochondria in diabetic kidney disease","volume":"19","author":"Ducasa","year":"2019","journal-title":"Curr Diab Rep"},{"issue":"10","key":"10.1016\/j.jpet.2026.104889_bib120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","article-title":"ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma","volume":"10","author":"Xi","year":"2019","journal-title":"Cell Death Dis"},{"issue":"13","key":"10.1016\/j.jpet.2026.104889_bib121","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.7150\/thno.41498","article-title":"ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma","volume":"10","author":"Tong","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jpet.2026.104889_bib122","first-page":"449","article-title":"Epidemiology and management of kidney stone disease \u2013 current insights","volume":"17","author":"Akram","year":"2025","journal-title":"Res Rep Urol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib123","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.41","article-title":"A new era in the treatment of calcium oxalate stones?","volume":"83","author":"Ivanovski","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib124","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-8529(02)00030-0","article-title":"Hyperoxaluric calcium nephrolithiasis","volume":"31","author":"Asplin","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jpet.2026.104889_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1625100","article-title":"Prevalence of kidney stones based on metabolic health and weight criteria: reports from the national health and nutrition examination survey 2007-2018 data analysis","volume":"16","author":"Ding","year":"2025","journal-title":"Front Physiol"},{"key":"10.1016\/j.jpet.2026.104889_bib126","series-title":"Renal Calculi, Nephrolithiasis","author":"Leslie","year":"2025"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib127","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1359\/jbmr.081245","article-title":"Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity","volume":"24","author":"Okada","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1681\/ASN.2015111271","article-title":"Genome-wide gene expression profiling of Randall\u2019s plaques in calcium oxalate stone formers","volume":"28","author":"Taguchi","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib129","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12967-019-2022-0","article-title":"Kidney injury in response to crystallization of calcium oxalate leads to rearrangement of the intrarenal T cell receptor delta immune repertoire","volume":"17","author":"Zhu","year":"2019","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.jpet.2026.104889_bib130","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1096\/fj.202000786R","article-title":"The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.jpet.2026.104889_bib131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0706770","article-title":"Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules","volume":"148","author":"Briscoe","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104889_bib132","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3945\/ajcn.2010.29479","article-title":"Associations of dietary fat with albuminuria and kidney dysfunction","volume":"92","author":"Lin","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib133","doi-asserted-by":"crossref","first-page":"960","DOI":"10.5301\/jn.5000284","article-title":"Dietary fat modification in patients with chronic kidney disease: n-3 fatty acids and beyond","volume":"26","author":"Huang","year":"2013","journal-title":"J Nephrol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104889_bib134","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3390\/nu13093138","article-title":"Dietary lipids and dyslipidemia in chronic kidney disease","volume":"13","author":"Kochan","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.jrn.2006.04.022","article-title":"Implications of chronic kidney disease for dietary treatment in cardiovascular disease","volume":"16","author":"Packard","year":"2006","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jpet.2026.104889_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108784","article-title":"Biased agonism at free-fatty acid receptor-4 (FFA4\/GPR120)","volume":"266","author":"Teyani","year":"2025","journal-title":"Pharmacol Ther"},{"issue":"6640","key":"10.1016\/j.jpet.2026.104889_bib137","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6220","article-title":"Unsaturated bond recognition leads to biased signal in a fatty acid receptor","volume":"380","author":"Mao","year":"2023","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj2384","article-title":"Structural basis for the ligand recognition and signaling of free fatty acid receptors","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.jpet.2026.104889_bib139","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease","volume":"35","author":"Mas","year":"2016","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.jpet.2026.104889_bib140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00467-025-06780-8","article-title":"Pediatric and adult point of view on the gut-kidney axis in CKD","volume":"41","author":"Holle","year":"2026","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpet.2026.104889_bib141","first-page":"1","article-title":"Gut dysbiosis in kidney injury: therapeutic potential of fecal microbiota transplantation","volume":"31","author":"Liu","year":"2026","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104889_bib142","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/biomedicines14010109","article-title":"Gut-kidney axis: unraveling the role of the microbiome in chronic kidney disease","volume":"14","author":"Rusu","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpet.2026.104889_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1661037","article-title":"Gut microbiota dysbiosis in diabetic nephropathy: mechanisms and therapeutic targeting via the gut-kidney axis","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.jpet.2026.104889_bib144","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526010888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526010888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:07:34Z","timestamp":1782720454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526010888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":144,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0022356526010888"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104889","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The roles of free-fatty acid receptors in the pathophysiology of renal disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104889"}}